Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Cash & Equivalents (2012 - 2026)

Updated

Skye Bioscience's Cash & Equivalents came in at $8.07 million for Q2 2026, down 66.2% from $23.84 million a year earlier and down 1.0% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Cash & Equivalents (2012 - 2026) Analysis & Trends

At the end of FY2025, Skye Bioscience's Cash & Equivalents was $5.88 million, down 91.4% from FY2024.

  • Cash & Equivalents carries a five-year compound annual growth rate of 19.0% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $68.42 million in FY2024, $1.26 million in FY2023 (+1.0%), $1.24 million in FY2022 (-86.1%) and $8.98 million in FY2021 (+263.8%).
  • The five-year range for quarterly Cash & Equivalents is $415,389 (Q3 2022) to $83.34 million (Q1 2024).
  • Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 70.8% over the last six quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 263.8%), and the weakest in Q3 2022 (a decline of 96.3%).
  • Business Quant data shows SKYE's Cash & Equivalents at $8.15 million (Q1 2026), $5.88 million (Q4 2025) and $18.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn - 4.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.82 Mn
Jun 30, 2026 8.07 Mn
Mar 31, 2026 8.15 Mn
Dec 31, 2025 5.88 Mn
Sep 30, 2025 18.44 Mn
Jun 30, 2025 23.84 Mn
Mar 31, 2025 46.42 Mn
Dec 31, 2024 68.42 Mn
Sep 30, 2024 67.41 Mn
Jun 30, 2024 74.12 Mn
Mar 31, 2024 83.34 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 5.13 Mn
Jun 30, 2023 553,443.00
Mar 31, 2023 2.67 Mn
Dec 31, 2022 1.24 Mn
Sep 30, 2022 415,389.00
Jun 30, 2022 2.93 Mn
Mar 31, 2022 6.01 Mn
Dec 31, 2021 8.98 Mn
API Access

Skye Bioscience Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SKYE&period=max&api_key=YOUR_API_KEY